Next Article in Journal
The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors
Previous Article in Journal
Sensitivity of Rodent Microglia to Kynurenines in Models of Epilepsy and Inflammation In Vivo and In Vitro: Microglia Activation Is Inhibited by Kynurenic Acid and the Synthetic Analogue SZR104
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 21
Issue 24
10.3390/ijms21249334
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

AmOctα2R: Functional Characterization of a Honeybee Octopamine Receptor Inhibiting Adenylyl Cyclase Activity

by
Wolfgang Blenau
1,
Joana Alessandra Wilms
2,
Sabine Balfanz
2 and
Arnd Baumann
2,*
1
Institute of Biochemistry, Leipzig University, 04103 Leipzig, Germany
2
Institute of Biological Information Processing, IBI-1, Research Center Jülich, 52428 Jülich, Germany
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(24), 9334; https://doi.org/10.3390/ijms21249334
Submission received: 14 July 2020 / Revised: 4 December 2020 / Accepted: 6 December 2020 / Published: 8 December 2020
(This article belongs to the Section Molecular Neurobiology)
Browse Figures
Versions Notes

Abstract

:
The catecholamines norepinephrine and epinephrine are important regulators of vertebrate physiology. Insects such as honeybees do not synthesize these neuroactive substances. Instead, they use the phenolamines tyramine and octopamine for similar physiological functions. These biogenic amines activate specific members of the large protein family of G protein-coupled receptors (GPCRs). Based on molecular and pharmacological data, insect octopamine receptors were classified as either α- or β-adrenergic-like octopamine receptors. Currently, one α- and four β-receptors have been molecularly and pharmacologically characterized in the honeybee. Recently, an α2-adrenergic-like octopamine receptor was identified in Drosophila melanogaster (DmOctα2R). This receptor is activated by octopamine and other biogenic amines and causes a decrease in intracellular cAMP ([cAMP]i). Here, we show that the orthologous receptor of the honeybee (AmOctα2R), phylogenetically groups in a clade closely related to human α2-adrenergic receptors. When heterologously expressed in an eukaryotic cell line, AmOctα2R causes a decrease in [cAMP]i. The receptor displays a pronounced preference for octopamine over tyramine. In contrast to DmOctα2R, the honeybee receptor is not activated by serotonin. Its activity can be blocked efficiently by 5-carboxamidotryptamine and phentolamine. The functional characterization of AmOctα2R now adds a sixth member to this subfamily of monoaminergic receptors in the honeybee and is an important step towards understanding the actions of octopamine in honeybee behavior and physiology.

Graphical Abstract

1. Introduction

The phenolamines tyramine and octopamine act as neurotransmitters, neuromodulators, and/or neurohormones in insects as well as other protostomes and play a significant role in the regulation of physiology and behavior of these animals (for recent reviews, see [1,2,3,4,5,6]). During the last decades, the honeybee (Apis mellifera (A. mellifera)) has become established as an important model organism for investigating the roles of biogenic amines on behavioral plasticity [7,8,9,10,11,12] and social behavior [13,14,15]. Physiologically, octopamine and tyramine are often considered to act similarly in the honeybee [16,17,18]. However, there is growing evidence for distinct effects of these two closely related amines on behavior in the bee [13,19,20] and the vinegar fly Drosophila melanogaster (D. melanogaster) [21,22,23,24,25,26]. Whether and how these effects can be traced back to the repertoire and the signaling capabilities of individual receptors is a challenging question.
Like other biogenic amines, tyramine and octopamine exert their actions by binding to the members of the superfamily of G protein-coupled receptors (GPCRs). For each phenolamine, there are multiple receptor subtypes that couple to various intracellular signaling pathways in a receptor subtype specific manner. In the honeybee, two tyramine receptors have been examined functionally so far. The AmTAR1 receptor (previously named AmTYR1) inhibits adenylyl cyclase activity and thus leads to a reduction in [cAMP]i [27,28,29]. More recently, a second tyramine receptor, AmTAR2, has been characterized that specifically induces cAMP production upon activation [30]. The family of octopamine receptors in the honeybee is more complex [31,32]. At the cellular level, these receptors evoke Ca2+ release from intracellular stores (AmOctαR, previously named AmOA1 [31]) or activate adenylyl cyclases, thereby increasing [cAMP]i (AmOctβR1–4 [32]). Recently, a novel octopamine receptor subtype was characterized in the rice stem borer, Chilo suppressalis (C. suppressalis; CsOctα2R = CsOA3 [33]) and D. melanogaster (DmOctα2R; CG18208 [34]). Interestingly, the activation of DmOctα2R resulted in inhibition of forskolin-stimulated cAMP synthesis [34]. Thus, a signaling pathway is activated that was formerly not known to be used by octopamine. In addition, DmOctα2R displays an unusual pharmacological profile and is also activated by tyramine and the indoleamine serotonin in a dose-dependent manner [34].
A gene potentially encoding an α2-adrenergic-like octopamine receptor was also identified in the honeybee genome [33,34,35]. The aim of the current study was to molecularly and pharmacologically characterize this AmOctα2R receptor. Therefore, upon cloning the complete coding sequence from honeybee brain cDNA, we constitutively expressed AmOctα2R in a cell line and examined its coupling to intracellular second messengers and its pharmacological properties. Intriguingly, receptor activation with octopamine led to a decrease in [cAMP]i. We showed that AmOctα2R had a clear preference for octopamine over tyramine (~30-fold difference in half-maximal reduction of cAMP levels (EC50)). In contrast to DmOctα2R, however, AmOctα2R was not activated by serotonin. We concluded that in vivo effects of octopamine on second messenger signaling depended on the tissue- and cell-type-specific expression patterns of the various receptor subtypes and, additionally, on potential cross-activation of tyramine receptors.

2. Results

2.1. Molecular and Structural Properties of AmOctα2R

The amino acid sequence of a potential α2-adrenergic-like octopamine receptor from the honeybee has been annotated in previous studies [33,34,35]. Here, we have cloned the complete cDNA-encoding AmOctα2R by PCR on single-stranded cDNA synthesized on mRNA of adult worker bee brains. The cDNA contained an open reading frame (ORF) of 2223 bp. The corresponding gene was located on chromosome LG15 (see NCBI: NC_007084.3) and consisted of three exons (Supplementary Figure S1 and Table S1).
The deduced amino acid sequence consisted of 741 residues with a calculated molecular weight of 80.7 kDa. The hydrophobicity profile according to Kyte and Dolittle [36] and the prediction of transmembrane (TM) helices using TMHMM Server v.2.0 [37] suggested seven TM domains (Figure 1a,b), which is a characteristic feature of GPCRs. The TM segments were flanked by an extracellular N-terminus of 263 residues and a short intracellular C-terminus of 14 residues. We submitted the AmOctα2 sequence to Phyre2 [38] and obtained a three-dimensional model of the receptor. In this model, the N-terminus was almost unstructured and loosely attached to the TM domains eventually crossing the membrane as an eighth TM segment. We, therefore, omitted the first 217 residues of the primary structure and recalculated the model from residue 218 to 741. This was revealed in the typical membrane arrangement of a GPCR (Figure 1c).
The sequence of AmOctα2R contained several putative sites for posttranslational modification (Supplementary Figure S2). Four potential N-glycosylation sites (N-X-(S/T)) were present in the extracellular N-terminus: N27MT, N164NT, N238GS, and N243ET. Conserved cysteine residues (C336 and C414) in the first and second extracellular loops might form a disulfide bridge as found in other biogenic amine receptors [39]. Five consensus sites for phosphorylation by protein kinase C and one consensus site for phosphorylation by protein kinase A were found in the cytoplasmic domains of the receptor protein (Supplementary Figure S2).
In addition to these sites, several cognate sequence motifs of GPCRs were identified in the primary structure of AmOctα2R. The D360RY motif (D3.49R3.50Y3.51; labeled according to [40] was located at the cytoplasmic end of TM3. In TM7, the residues N720PFIY (N7.49P7.50F7.51I7.52Y7.53) constituted part of the hydrophobic interaction site with the phenyl moiety of the biogenic amine. Furthermore, residues that most likely bound to the ligand (e.g., D343 (D3.32) and S426/430 (S5.42/5.46)) were highly conserved within the family of biogenic amine receptors [41].
The phylogenetic relationship of the AmOctα2R receptor was examined using MEGA7 software (Figure 2). Not all receptors binding to a certain biogenic amine were composed of uniform clusters, but the appropriate receptor subgroups did. AmOctα2R assembled in a clade that contained an α2-adrenergic-like octopamine receptor from D. melanogaster [34] and α2 adrenergic receptors from Platynereis dumerilii (Pdα2 [42]), Saccoglossus kowalevskii (Skα2 [42]), and Priapulus caudatus (Pcα2 [42]). This clade was closely related to human α2-adrenergic receptors. In contrast, α1-adrenergic-like octopamine receptors including AmOctα1R [31] were clearly set apart and formed a sister group with α1-adrenergic receptors (Figure 2). Both α1-adrenergic-like octopamine receptors and α1-adrenergic receptors were also closely related to the invertebrate-type dopamine receptors from A. mellifera (AmDOP2 [43]), Periplaneta americana (P. americana; PaDOP2 [44]), and D. melanogaster (DmDOP2 [45]).
The complete primary structures of the AmOctα1R [31] and AmOctα2R receptors were only 22.1% identical and 33.5% similar. Notably, AmOctα2R was more closely related to α2-adrenergic-like octopamine receptors from the striped rice stemborer C. suppressalis (47.8%/55.1%), the red flour beetle Tribolium castaneum (46.3%/53.3%), and D. melanogaster (43.3%/50.8%).

2.2. Expression of AmOctα2R-HA in flpTM Cells

To unravel the intracellular signaling pathway activated by AmOctα2R-HA and determine its pharmacological properties, flpTM cells were stably transfected with the expression construct. Independent cell lines were obtained and examined by immuno-fluorescence staining for homogeneity (Supplementary Figure S3). Additionally, AmOctα2R-HA was examined by Western blotting (Figure 3). The anti-(hemagglutinin A) HA antibody labeled a band of ~117 kDa (Figure 3a, lanes 1 and 2), which was absent in flpTM cells (Figure 3a, lane 3). Thus, the apparent molecular weight of the receptor was significantly greater than the calculated molecular weight of AmOctα2R-HA (81.8 kDa). Whether this difference was due to glycosylation was assessed by treating samples with and without PNGaseF separately. The mobility of the protein was not altered by PNGaseF treatment (Figure 3a, lanes 1 and 2), suggesting that AmOctα2R-HA was not glycosylated in these cells. As an internal control, the blot was developed with an antibody directed against the cyclic nucleotide-gated (CNG) channel (Figure 3b). In this case, the treatment with PNGaseF resulted in a reduction of the apparent molecular weight of the channel protein (Figure 3b, lane 2). Therefore, the difference between the apparent and calculated molecular weights of AmOctα2R-HA is possibly due to receptor dimerization and other post-translational modifications, e.g., phosphorylation or unusual electrophoretic mobility under denaturing conditions.

2.3. Ligand Specificity of the AmOctα2R-HA Receptor

The α2-adrenergic octopamine receptors from C. suppressalis [33] and D. melanogaster [34] have been shown to attenuate [cAMP]i upon activation. We examined whether AmOctα2R-HA might also couple to Gi-type G proteins, thereby causing inhibition of cell-endogenous adenylyl cyclases. To examine AmOctα2R-HA’s coupling properties, cells were treated with a water-soluble forskolin analog, NKH 477, which stimulated membrane-bound adenylyl cyclases. NKH 477 led to cAMP production in both nontransfected and AmOctα2R-HA-expressing flpTM cells. Next, we assessed the effects of the biogenic amines octopamine, tyramine, dopamine, and serotonin (10−6 M each) on NKH 477-stimulated cAMP production. The application of octopamine and tyramine led to a decrease in the Ca2+-dependent fluorescence signal, whereas the other amines had no effect on such signals. Cells that did not express the receptor (flpTM) showed no Ca2+-dependent responses after the application of biogenic amines.
To further investigate AmOctα2R-HA’s properties, the concentration–response curves for octopamine and tyramine were established. Octopamine was applied in concentrations ranging from 10−9 M to 10−4 M. Unexpectedly the concentration–response curve was U-shaped (Figure 4). A decrease in fluorescence was observed with octopamine concentrations ranging from 10−9 M to 10−6 M. Considering octopamine concentrations from 10−9 M to 3 × 10−6 M, EC50 was observed with 1.17 × 10−7 M octopamine (logEC50 ± SD = −6.932 ± 0.1395; for the mean values of all experiments, see Table 1). The maximal reduction of cAMP synthesis was ~25% at 10−6 M octopamine. Octopamine concentrations higher than 10−6 M led to an increase in Ca2+-dependent fluorescence signals (Figure 4), suggesting that the parental flpTM cell line expresses receptors that could be activated by octopamine and cause either a cAMP response and/or direct Ca2+ responses [47]. To test this hypothesis, nontransfected flpTM cells were incubated with increasing octopamine concentrations (Figure 5). In the presence of NKH 477, octopamine concentrations of ≥ 3 × 10−7 M led to an increase in Fluo-4 fluorescence, which argued for the presence of such endogenous receptors. Although we did not address the molecular identity of these receptors, they most likely belong to the family of the adrenergic GPCRs that have been previously found in these cells [48].
The concentration–response curve for tyramine was sigmoid and saturated at a tyramine concentration of ≥3 × 10−5 M (~17% reduction; Figure 6). The ligand concentration leading to the half-maximal activation of AmOctα2R-HA (EC50) was 1.628 × 10−6 M tyramine (logEC50 ± SD = −5.788 ± 0.092; for the mean values of all experiments, see Table 1). In nontransfected flpTM cells, no change in the fluorescence signal was observed upon application of tyramine. Accordingly, all subsequent measurements with antagonists (see below) were first carried out against a tyramine background. In conclusion, the results indicated that AmOctα2R-HA has a clear (~30-fold) specificity for octopamine over tyramine and can be considered a functional α2-adrenergic-like octopamine receptor.

2.4. Pharmacological Properties of the AmOctα2R-HA Receptor

The ability of various potential antagonists for impairing AmOctα2R-HA activity was assessed in a similar way. Measurements were performed with increasing concentrations of antagonists AS-19, 5-carboxamidotryptamine (5-CT), 5-methoxytryptamine (5-MT), 8-Hydroxy-2-(dipropylamino)tetralin (8-OH-DPAT), epinastine, ketanserin, mianserin, phentolamine, and yohimbine on a nonsaturating tyramine background (10 µM). In NKH 477-treated and tyramine-stimulated AmOctα2R-HA expressing cells, the application of antagonists led to an increase in the fluorescence signal, because adenylyl cyclases were no longer inhibited by Gi-proteins. In Figure 7, the antagonistic effects of phentolamine, epinastine, mianserin, and yohimbine are displayed. Ligand concentrations that led to the half-maximal inhibition of AmOctα2R-HA (IC50) were determined from the concentration–response curves and are summarized in Table 2. Effective antagonists of tyramine-stimulated AmOctα2R-HA were, for example, 5-CT and phentolamine with IC50 values of 4.16 × 10−9 M and 5.6 × 10−9 M. The order of antagonist potency of tyramine-stimulated AmOctα2R-HA was 5-CT ≥ phentolamine > epinastine > 5-MT > mianserin > yohimbine > ketanserin > 8-OH-DPAT (for mean values of IC50, see Table 2). AS-19 did not show any effect.
Substances, which showed antagonistic activity at AmOctα2R-HA against a tyramine background, were also tested against an octopamine background (3 × 10−7 M). The rank order of potency was similar to measurements performed with tyramine. The mean values for half-maximal inhibition (IC50 [M] and logIC50 ± SD) are summarized in Table S3.

3. Discussion

There is ongoing interest in precisely understanding the physiological and behavioral roles of octopaminergic signaling in insects [2,6,26,49,50,51]. An important step to meet this challenge is to determine the molecular and functional pharmacological properties of octopamine receptor subtypes. Here, we described the functional characterization of AmOctα2R, the sixth octopamine receptor subtype of the honeybee. The primary structure of AmOctα2R phylogenetically clustered with protostomian α2-adrenergic-like octopamine receptors. Activation of AmOctα2R by the phenolamines octopamine and tyramine led to a substantial decrease of NKH 477-induced cAMP synthesis. In contrast to DmOctα2R from D. melanogaster [34], we did not observe any changes in [cAMP]i in response to the indoleamine serotonin.

3.1. Gene Structure, Structural Properties of the Protein, and Phylogenetic Classification

The coding region of the AmOctα2R gene was dispersed over approximately 13 kb of genomic DNA on the linkage group LG15 and was interrupted by two introns. The gene was located on the same chromosome, as the AmOctα1R gene of which the coding region was interrupted by eight introns (Table S1, Figure S1; [31,35]). Whereas the position of intron 1 was conserved between orthologous receptors of A. mellifea and D. melanogaster, this is not the case for intron 2 (Figure S1). Since amplification on brain cDNA resulted in only one distinct product, we found no evidence for alternative splicing of the AmOctα2R transcript, as has been described for transcripts of orthologous receptors of both C. suppressalis [33] and D. melanogaster [34].
Applying several in silico analyses confirmed that AmOctα2R is a member of the class A (rhodopsin-like) GPCR family. This assessment was supported by the presence of cognate amino acid residues and motifs within the TM segments in AmOctα2R, e.g., N720PFIY in TM7 or the D360RY motif at the C-terminal end of TM3.
Most class A (rhodopsin-like) GPCRs were activated by ligands docking to specific residues in the binding pocket of the receptor near the extracellular side. Functionally important amino acid residues present in α2-adrenergic-like octopamine receptors were well conserved in the AmOctα2R sequence. They were an aspartic acid residue (D342) in TM3 and two of three closely grouped serine residues found in TM5 (S426,430) (see Supplementary Figure S2). Octopamine appeared to bind via its amine group and its hydroxyl group to the aspartic acid and one of the serine residues of the receptor, respectively [52,53]. In addition, phenylalanine and/or tryptophan residues in TM6 and TM7 (see Supplementary Figure S2) might contribute to π–π interaction with delocalized electrons in octopamine or tyramine and stabilize the receptor ligand interaction.
The coupling of GPCRs to specific G proteins is brought about by amino-acid residues in close vicinity to the plasma membranes of the 2nd and 3rd intracellular loops and of the cytoplasmic C-terminus of the receptor [54,55,56]. Biogenic amine receptors that couple to Gi proteins and thereby inhibit adenylyl cyclase activity often possess short C termini [54]. This feature is conserved in AmOctα2R and in other α2-adrenergic-like octopamine receptors (Supplementary Figure S2; [33,34]). In addition, the receptors possess strikingly similar amino-acid sequences in the vicinity of TM5 and TM6 within their 3rd cytoplasmic loops, a region largely determining the specificity of receptor/G protein coupling [57].
Our phylogenetic analysis including all major insect biogenic amine GPCR families resulted in a well-resolved phylogram (Figure 2). Protostomian α2-adrenergic-like octopamine receptors seemed to be closely related to deuterostomian α2-adrenergic receptors, emphasizing the idea of “ligand-hopping” during evolution of aminergic GPCRs [35]. When new receptors evolved by gene duplication, they needed new ligands. Because of structural constraints, the only way to obtain “new” aminergic ligands was to repurpose already existing biogenic amines from other systems. The frequent ligand exchanges during evolution of aminergic GPCRs strongly contrasted the situation observed for neuropeptide and protein hormone GPCRs, where generally co-evolution between receptors and their ligands takes place [35,58,59].
The sister group of both α2-adrenergic-like octopamine and α2-adrenergic receptors constituted type 1 tyramine receptors which also couple to Gi proteins (Figure 2; [33,34]). A slightly different assignment of the α2-adrenergic-like octopamine receptor family has been described in an independent study. Here, the phylogenetic trees were calculated with RAxML using the CIPRES Science Gateway [42]. The α2-adrenergic-like octopamine receptors assembled at the basal branches of the dendrogram forming the sister group of all other tyramine-, octopamine-, and adrenergic receptors. The different results may originate from the strategies applied in creating the datasets used for calculating the phylograms. Based on our results, we suggest including all major receptor families to unravel the evolutionary relationship of biogenic amine receptors.

3.2. Posttranslational Modification of AmOctα2R

Posttranslational modifications in intracellular loops of AmOctα2R, like phosphorylation, may also affect the signaling properties of the protein. It has been recently shown that phosphorylation of a single residue in the third intracellular loop of an octopamine receptor from D. melanogaster (DmOctαR1B; [60,61] is sufficient to explain the receptor’s oscillatory Ca2+ signaling behavior [62]. Whether transient changes in the surface charge of AmOctα2R also lead to oscillatory phases of adenylyl cyclase inhibition remains to be addressed. Cysteine residues in the C-terminus of different biogenic amine receptors were found to undergo posttranslational palmitoylation [63]. This modification generates a fourth intracellular loop that also participates in receptor–G protein binding [59]. Since a cysteine is missing in the C-terminus of AmOctα2R, the fourth intracellular loop does not exist in this GPCR.

3.3. Pharmacological Properties of the AmOctα2R Protein

The AmOctα2R receptor was functionally expressed in flpTM cells. The coupling of AmOctα2R to intracellular signaling cascades was examined via cell-endogenous G proteins. AmOctα2R, like other α2-adrenergic-like octopamine receptors from insects [33,34] and mammalian α2-adrenergic receptors (for a review, see [64]), was negatively coupled to the enzyme adenylyl cyclase via Gi proteins and thus resulted in a decrease in [cAMP]i. With a mean EC50 of 58.7 nM, activation of AmOctα2R was much more sensitive to octopamine than to tyramine (mean EC50 = 1.85 µM; Table 1). These data agree well with those described for orthologous receptors [33,34]. Interestingly, besides cAMP signaling, the addition of octopamine, tyramine (and dopamine) to CsOctα2R-expressing HEK 293 cells also resulted in concentration-dependent increases in [Ca2+]i. This has not been found for DmOctα2R- [34] or AmOctα2R-expressing cells (this study). However, apart from obvious similarities in the pharmacological properties, there were also significant differences between DmOctα2R and AmOctα2R. Whereas DmOctα2R was activated by serotonin in a dose-dependent manner (EC50 = 1.04 µM; [34]), serotonin failed to activate AmOctα2R.
The inhibition of AmOctα2R-HA-mediated attenuation of [cAMP]i in the cell line was examined with various synthetic antagonists. In addition to phentolamine (IC50 = 5.6 nM/8.21 nM) which is a nonselective α-adrenergic antagonist (for a review, see [65]), the action of tyramine and octopamine on AmOctα2R could also be blocked by 5-CT (IC50 = 4.16 nM/0.27 nM) with even slightly higher potency. The substance 5-CT is primarily known as an agonist at 5-HT1A, 5-HT1B, 5-HT1D, 5-HT5, and 5-HT7 receptors in mammals [66] and in insects [11,67,68]. Additional serotonergic ligands (e.g., the agonist 5-MT (IC50 = 20.6 nM/836 nM) and the antagonist mianserin (IC50 = 29.5 nM/21.5 nM)) were also potent blockers of the action of tyramine and octopamine on AmOctα2R. Mianserin is known for some time as a potent antagonist at octopamine receptors [69,70] and, more recently, was found to be an antagonist of the AmTAR2 receptor of the honeybee [30] and the PeaTAR1B receptor of the American cockroach, P. americana [71].
Overall, our results support the notion that octopamine signaling in insects is highly complex. It is noteworthy that octopamine receptors characterized so far have been shown to preferentially couple to Gs proteins to activate adenylyl cyclases and to Gq-proteins, which induce intracellular Ca2+ mobilization (for reviews, see [2,4,72]. However, α2-adrenergic-like octopamine receptors have been found to inhibit adenylyl cyclase activity ([33,34] and this study), a property reminiscent of the phylogenetically related mammalian α2-adrenergic receptors (for a review, see [64]) and insect type 1 tyramine receptors (e.g., [27,28,47,71,73,74,75]). Whether the signaling properties of a given receptor in a cell line illustrates its typical behavior in a natural background would require experimental testing in native cell or tissue samples. To the best of our knowledge, only stimulatory actions of octopamine on adenylyl cyclase activity have been reported so far for native tissues of the honeybee [27,72] and other insects [76,77,78,79,80] as well as for insect cells lines [81,82,83]. We speculate that the inhibitory effects of α2-adrenergic-like octopamine receptors on adenylyl cyclase activity are masked by the effects of the more prominent α1-adrenergic-like and β-adrenergic-like octopamine receptors. To test this hypothesis, native cells, tissue, or organs should be identified that express AmOctα2R as the only phenolamine receptor. An alternative could be the use of well-characterized pharmacological tools that permit the selective and efficient activation or inhibition of one or the other receptor in preparations expressing more than one phenolamine receptor. We have successfully used such a strategy to disentangle the signaling pathways of 5-HT2 and 5-HT7 serotonin receptors, which are co-expressed in blowfly (Calliphora vicina) salivary glands [84]. In any case, the characterization of the signaling properties of a sixth member of the octopamine receptor family presented here for the honeybee should facilitate future in vivo pharmacological studies coupled with behavioral testing in this eusocial model organism.

4. Materials and Methods

4.1. Amplification of the Honeybee α2-Adrenergic-Like Octopamine Receptor (AmOctα2R) cDNA and Construction of pcAmOctα2R-HA Expression Vector

Total RNA was extracted from 10 brains of honeybee foragers using the RNeasy Plus Micro Kit (Qiagen, Hilden, Germany). Synthesis of cDNA was carried out with M-MLV Reverse Transcriptase (Invitrogen/ThermoFisher Scientific, Dreieich, Germany). For the amplification of the entire coding region of AmOctα2R, specific primers were designed based on available sequence information ([35]; GenBank accession number XM_001122075): sense primer 5′-CGAGGAATTCCACCATGCCGCTCCTCGGCACC-3′; antisense primer 5′-GACGTCTAGATTATGCATAGTCGGGGACGTCATAGGGATATTTGAAGAGTATCCTGCGG-3′ (eurofins, Ebersberg, Germany). Primers were designed to enable ligation into pcDNA3.1(+) vector (Invitrogen/ThermoFisher Scientific, Dreieich, Germany) and heterologous expression of AmOctα2R in eukaryotic cells. In the sense primer, an EcoRI restriction site and a Kozak consensus motif (CCACC; [85]) were inserted in front of the translational start codon. In the antisense primer, the receptor-encoding sequence was extended in a frame with a sequence encoding the hemagglutinin A (HA) tag to allow monitoring of receptor protein expression using specific anti-HA antibodies (Roche/Sigma-Aldrich/Merck, Darmstadt, Germany). In addition, an XbaI recognition sequence was introduced immediately after the stop codon (TAA). PCR was performed using the following protocol: 95 °C for 10 min, 35 cycles at 95 °C for 30 s, 65 °C for 30 s, and 72 °C for 150 s and a final extension at 72 °C for 5 min. The PCR product was separated by agarose gel electrophoresis. The fragment was excised from the gel, cleaned using a PCR clean-up and gel extraction kit (Macherey-Nagel, Düren, Germany), double-restricted with EcoRI and XbaI and cloned into the pcDNA3.1(+) vector. The expression construct (pcAmOctα2R-HA) was verified by sequencing on both strands (eurofins).

4.2. Multiple Sequence Alignment and Phylogenetic Analysis

For phylogenetic analysis, we included amino acid sequences of biogenic amine receptors of various protostomian and deuterostomian species. Sequences were obtained from NCBI databases (NCBI, Bethesda, MD, USA). Multiple amino acid sequence alignment was consequently trimmed to regions encoding TM 1–4, TM 5, TM 6, and TM 7 using ClustalW. Afterwards, evolutionary analyses were conducted in MEGA7 [86]. The evolutionary history was inferred using the neighbor-joining method [87] with 10,000-fold bootstrap resampling. The human rhodopsin sequence formed the outgroup.
The sequence identity and similarity of α2-adrenergic-like octopamine receptors between A. mellifera, B. mori, and D. melanogaster were determined by using BioEdit v. 7.0.5.3 [88] after pairwise alignment.

4.3. Functional Expression of the AmOctα2R-HA Receptor

For AmOctα2R-HA expression and pharmacological analysis, we used a human embryonic kidney (HEK293; flpIn cells; Invitrogen/ThermoFisher Scientific; #750-07)-based cell line that was transfected with a gene encoding a variant of the A2-subunit of the olfactory CNG ion channel [89] (flpTM cells), provided by Sibion biosciences, Jülich, Germany. These flpTM cells were transfected with 3 µg, 8 µg, or 12 µg of the pcAmOctα2R-HA construct by a modified calcium phosphate method [90] following a previously established protocol [48]. Transfected cells were selected in the presence of the antibiotics G418 (1 mg/mL) and hygromycin (100 µg/mL). Expression of AmOctα2R-HA was monitored by Western blotting and immunocytochemistry using anti-HA antibodies (Roche/Sigma-Aldrich/Merck).

4.4. Functional Analysis of the AmOctα2R-HA Receptor

A stably transfected cell line was used to examine AmOctα2R-HA receptor activity by Ca2+ imaging. Control measurements were performed in the parental (flpTM) cell line. Changes in [cAMP]i were registered indirectly via co-expressed CNG channels that were opened by cAMP and cause an influx of extracellular Ca2+ [30,32,48]. Changes in [Ca2+]i were monitored with the Ca2+-sensitive fluorescent dye Fluo-4. Cells were grown in 96-well dishes to a density of approximately 2 × 104 cells per well and were loaded at room temperature with Fluo-4 AM as described previously [32]. After 90 min, the loading solution was substituted with a dye-free extracellular solution (ECS; 120 mM NaCl, 5 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 10 mM HEPES, and 10 mM glucose, pH 7.4 (NaOH)) containing 100 µM IBMX. The plate was transferred into a fluorescence reader (FLUOstar Omega, BMG Labtech, Ortenberg, Germany) to monitor Fluo-4 fluorescence. The excitation wavelength was 485 nm. Fluorescence emission was detected at 520 nm. Concentration series of various biogenic amines and synthetic receptor ligands were added, once Fluo-4 fluorescence intensity reached a stable value in each well. The changes in Fluo-4 fluorescence were recorded automatically. Concentration–response curves were established from at least three independent experiments with quadruplicate measurements. Data were analyzed and displayed using Prism 5.04 software (GraphPad, San Diego, CA, USA).

4.5. Western Blot analysis

Membrane proteins from AmOctα2R-HA-expressing cells and non-transfected flpTM cells were prepared as described previously [32]. Briefly, cells were lysed in buffer A (10 mM NaCl, 25 mM HEPES (pH 7.5), 2 mM EDTA, and a mammalian protease inhibitor cocktail diluted at 1:500 (mPIC; Sigma-Aldrich/Merck, Darmstadt, Germany)). After centrifugation, membrane proteins were solubilized from the pellet with buffer B (100 mM NaCl, 25 mM HEPES pH 7.5, mPIC protease inhibitor (dilution, 1:500) and 1% (w/v) (3-((3-cholamidopropyl)-dimethylammonio)-1-propanesulfonate, (CHAPS)). Proteins (30 µg per lane) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; 10% gel) and transferred onto a polyvinylidene fluoride membrane (PVDF, Merck/Millipore, Darmstadt, Germany). Nonspecific binding sites were blocked by incubation for 30 min in 5% (w/v) dry milk in phosphate buffered saline (PBS; 130 mM NaCl, 7 mM Na2HPO4, and 3 mM NaH2PO4; pH: 7.4). The membrane was incubated with primary antibodies (anti-HA; dilution, 1:1000; Roche/Sigma-Aldrich/Merck) in PBS containing 0.02% (v/v) Tween-20 (PBT) overnight at 4 °C. After rinsing the membrane three times with PBT for 15 min each, secondary antibodies conjugated to horseradish peroxidase (donkey anti-rat-HRP; dilution, 1:5000 (Sigma-Aldrich/Merck, Darmstadt, Germany)) in PBT containing 0.5% (w/v) dry milk were added for 1 h at room temperature. After rinsing the membrane three times with PBT for 15 min each and two times with PBS for 5 min each, signals were visualized with an enhanced chemiluminescence detection system (Western Bright™-Kit; Advansta; San Jose, CA, USA) on Hyperfilm™ ECL (GE Healthcare/Merck, Darmstadt, Germany).

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/1422-0067/21/24/9334/s1.

Author Contributions

Conceptualization, W.B. and A.B.; validation, W.B. and A.B.; formal analysis, W.B., J.A.W., and S.B.; investigation, W.B., J.A.W., and S.B.; writing of the original draft preparation, W.B. and A.B.; writing of review and editing, W.B., J.A.W., S.B., and A.B.; supervision, W.B. and A.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

The authors would like to thank Paul A. Stevenson (University of Leipzig) for the constructive criticism of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

5-CT5-carboxamidotryptamine
5-MT5-methoxytryptamine
5-HT5-hydroxytryptamine, serotonin
8-OH-DPAT8-Hydroxy-2-(dipropylamino)tetralin
GPCRG protein-coupled receptor
HAhemagglutinin A
IBMX3-isobutyl-1-methylxanthine
NKH477water-soluble forskolin analog
RFUrelative fluorescence unit
TMtransmembrane

References

  1. Blenau, W.; Baumann, A. Aminergic signal transduction in invertebrates: Focus on tyramine and octopamine receptors. Recent Res. Dev. Neurochem. 2003, 6, 225–240. [Google Scholar]
  2. Blenau, W.; Baumann, A. Octopaminergic and tyraminergic signaling in the honeybee (Apis mellifera) brain: Behavioral, pharmacological, and molecular aspects. In Trace Amines and Neurological Disorders, 1st ed.; Farooqui, A., Ed.; Academic Press: Oxford, UK, 2016; pp. 203–220. [Google Scholar]
  3. Lange, A.B. Tyramine: From octopamine precursor to neuroactive chemical in insects. Gen. Comp. Endocrinol. 2009, 162, 18–26. [Google Scholar] [CrossRef] [PubMed]
  4. Verlinden, H.; Vleugels, R.; Marchal, E.; Badisco, L.; Pflüger, H.J.; Blenau, W.; Vanden Broeck, J. The role of octopamine in locusts and other arthropods. J. Insect Physiol. 2010, 56, 854–867. [Google Scholar] [CrossRef] [PubMed]
  5. Ohta, H.; Ozoe, Y. Molecular signalling, pharmacology, and physiology of octopamine and tyramine receptors as potential insect pest control targets. Adv. Insect Physiol. 2014, 46, 73–166. [Google Scholar]
  6. Roeder, T. The control of metabolic traits by octopamine and tyramine in invertebrates. J. Exp. Biol. 2020, 223, jeb194282. [Google Scholar] [CrossRef]
  7. Hammer, M. An identified neuron mediates the unconditioned stimulus in associative olfactory learning in honeybees. Nature 1993, 366, 59–63. [Google Scholar] [CrossRef]
  8. Farooqui, T.; Robinson, K.; Vaessin, H.; Smith, B.H. Modulation of early olfactory processing by an octopaminergic reinforcement pathway in the honeybee. J. Neurosci. 2003, 23, 5370–5380. [Google Scholar] [CrossRef]
  9. Giurfa, M. Associative learning: The instructive function of biogenic amines. Curr. Biol. 2006, 16, R892–R895. [Google Scholar] [CrossRef] [Green Version]
  10. Vergoz, V.; Roussel, E.; Sandoz, J.C.; Giurfa, M. Aversive learning in honeybees revealed by the olfactory conditioning of the sting extension reflex. PLoS ONE 2007, 2, e288. [Google Scholar] [CrossRef]
  11. Thamm, M.; Balfanz, S.; Scheiner, R.; Baumann, A.; Blenau, W. Characterization of the 5-HT1A receptor of the honeybee (Apis mellifera) and involvement of serotonin in phototactic behavior. Cell. Mol. Life Sci. 2010, 67, 2467–2479. [Google Scholar] [CrossRef]
  12. Mancini, N.; Giurfa, M.; Sandoz, J.C.; Avarguès-Weber, A. Aminergic neuromodulation of associative visual learning in harnessed honey bees. Neurobiol. Learn. Mem. 2018, 155, 556–567. [Google Scholar] [CrossRef] [PubMed]
  13. Schulz, D.J.; Robinson, G.E. Octopamine influences division of labor in honey bee colonies. J. Comp. Physiol. A 2001, 187, 53–61. [Google Scholar] [CrossRef]
  14. Lehman, H.K.; Schulz, D.J.; Barron, A.B.; Wraight, L.; Hardison, C.; Whitney, S.; Takeuchi, H.; Paul, R.K.; Robinson, G.E. Division of labor in the honey bee (Apis mellifera): The role of tyramine β-hydroxylase. J. Exp. Biol. 2006, 209, 2774–2784. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Scheiner, R.; Baumann, A.; Blenau, W. Aminergic control and modulation of honeybee behaviour. Curr. Neuropharmacol. 2006, 4, 259–276. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Braun, G.; Bicker, G. Habituation of an appetitive reflex in the honeybee. J. Neurophysiol. 1992, 67, 588–598. [Google Scholar] [CrossRef] [PubMed]
  17. Scheiner, R.; Plückhahn, S.; Oney, B.; Blenau, W.; Erber, J. Behavioural pharmacology of octopamine, tyramine and dopamine in honey bees. Behav. Brain Res. 2002, 136, 545–553. [Google Scholar] [CrossRef]
  18. Cook, C.N.; Brent, C.S.; Breed, M.D. Octopamine and tyramine modulate the thermoregulatory fanning response in honey bees (Apis mellifera). J. Exp. Biol. 2017, 220, 1925–1930. [Google Scholar] [CrossRef] [Green Version]
  19. Fussnecker, B.L.; Smith, B.H.; Mustard, J.A. Octopamine and tyramine influence the behavioral profile of locomotor activity in the honey bee (Apis mellifera). J. Insect Physiol. 2006, 52, 1083–1092. [Google Scholar] [CrossRef] [Green Version]
  20. Scheiner, R.; Toteva, A.; Reim, T.; Søvik, E.; Barron, A.B. Differences in the phototaxis of pollen and nectar foraging honey bees are related to their octopamine brain titers. Front. Physiol. 2014, 5, 116. [Google Scholar] [CrossRef] [Green Version]
  21. Kutsukake, M.; Komatsu, A.; Yamamoto, D.; Ishiwa-Chigusa, S. A tyramine receptor gene mutation causes a defective olfactory behavior in Drosophila melanogaster. Gene 2000, 245, 31–42. [Google Scholar] [CrossRef]
  22. Saraswati, S.; Fox, L.E.; Soll, D.R.; Wu, C.F. Tyramine and octopamine have opposite effects on the locomotion of Drosophila larvae. J. Neurobiol. 2004, 58, 425–441. [Google Scholar] [CrossRef] [PubMed]
  23. Ormerod, K.G.; Hadden, J.K.; Deady, L.D.; Mercier, A.J.; Krans, J.L. Action of octopamine and tyramine on muscles of Drosophila melanogaster larvae. J. Neurophysiol. 2013, 110, 1984–1996. [Google Scholar] [CrossRef] [PubMed]
  24. Selcho, M.; Pauls, D.; el Jundi, B.; Stocker, R.F.; Thum, A.S. The role of octopamine and tyramine in Drosophila larval locomotion. J. Comp. Neurol. 2012, 520, 3764–3785. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Damrau, C.; Toshima, N.; Tanimura, T.; Brembs, B.; Colomb, J. Octopamine and tyramine contribute separately to the counter-regulatory response to sugar deficit in Drosophila. Front. Syst. Neurosci. 2018, 11, 100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Schützler, N.; Girwert, C.; Hügli, I.; Mohana, G.; Roignant, J.Y.; Ryglewski, S.; Duch, C. Tyramine action on motoneuron excitability and adaptable tyramine/octopamine ratios adjust Drosophila locomotion to nutritional state. Proc. Natl. Acad. Sci. USA 2019, 116, 3805–3810. [Google Scholar] [CrossRef] [Green Version]
  27. Blenau, W.; Balfanz, S.; Baumann, A. Amtyr1: Characterization of a gene from honeybee (Apis mellifera) brain encoding a functional tyramine receptor. J. Neurochem. 2000, 74, 900–908. [Google Scholar] [CrossRef] [PubMed]
  28. Mustard, J.A.; Kurshan, P.T.; Hamilton, I.S.; Blenau, W.; Mercer, A.R. Developmental expression of a tyramine receptor gene in the brain of the honey bee, Apis mellifera. J. Comp. Neurol. 2005, 483, 66–75. [Google Scholar] [CrossRef]
  29. Beggs, K.T.; Tyndall, J.D.A.; Mercer, A.R. Honey bee dopamine and octopamine receptors linked to intracellular calcium signaling have a close phylogenetic and pharmacological relationship. PLoS ONE 2011, 6, e26809. [Google Scholar] [CrossRef]
  30. Reim, T.; Balfanz, S.; Baumann, A.; Blenau, W.; Thamm, M.; Scheiner, R. AmTAR2: Functional characterization of a honeybee tyramine receptor stimulating adenylyl cyclase activity. Insect Biochem. Mol. Biol. 2017, 80, 91–100. [Google Scholar] [CrossRef]
  31. Grohmann, L.; Blenau, W.; Erber, J.; Ebert, P.R.; Strünker, T.; Baumann, A. Molecular and functional characterization of an octopamine receptor from honeybee (Apis mellifera) brain. J. Neurochem. 2003, 86, 725–735. [Google Scholar] [CrossRef] [Green Version]
  32. Balfanz, S.; Jordan, N.; Langenstück, T.; Breuer, J.; Bergmeier, V.; Baumann, A. Molecular, pharmacological, and signaling properties of octopamine receptors from honeybee (Apis mellifera) brain. J. Neurochem. 2014, 129, 284–296. [Google Scholar] [CrossRef] [PubMed]
  33. Wu, S.F.; Xu, G.; Qi, Y.X.; Xia, R.Y.; Huang, J.; Ye, G.Y. Two splicing variants of a novel family of octopamine receptors with different signaling properties. J. Neurochem. 2014, 129, 37–47. [Google Scholar] [CrossRef] [PubMed]
  34. Qi, Y.X.; Xu, G.; Gu, G.X.; Mao, F.; Ye, G.Y.; Liu, W.; Huang, J. A new Drosophila octopamine receptor responds to serotonin. Insect Biochem. Mol. Biol. 2017, 90, 61–70. [Google Scholar] [CrossRef] [PubMed]
  35. Hauser, F.; Cazzamali, G.; Williamson, M.; Blenau, W.; Grimmelikhuijzen, C.J. A review of neurohormone GPCRs present in the fruitfly Drosophila melanogaster and the honey bee Apis mellifera. Prog. Neurobiol. 2006, 80, 1–19. [Google Scholar] [CrossRef] [Green Version]
  36. Kyte, J.; Doolittle, R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982, 157, 105–132. [Google Scholar] [CrossRef] [Green Version]
  37. Krogh, A.; Larsson, B.; von Heijne, G.; Sonnhammer, E.L. Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes. J. Mol. Biol. 2001, 305, 567–580. [Google Scholar] [CrossRef] [Green Version]
  38. Kelley, L.A.; Mezulis, S.; Yates, C.M.; Wass, M.N.; Sternberg, M.J. The phyre2 web portal for protein modeling, prediction and analysis. Nat. Protoc. 2015, 10, 845–858. [Google Scholar] [CrossRef] [Green Version]
  39. Kroeze, W.K.; Sheffler, D.J.; Roth, B.L. G-protein-coupled receptors at a glance. J. Cell Sci. 2003, 116, 4867–4869. [Google Scholar] [CrossRef] [Green Version]
  40. Ballesteros, J.A.; Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 1995, 25, 366–428. [Google Scholar]
  41. Eilers, M.; Hornak, V.; Smith, S.O.; Konopka, J.B. Comparison of class a and dg protein-coupled receptors: Common features in structure and activation. Biochemistry 2005, 44, 8959–8975. [Google Scholar] [CrossRef] [Green Version]
  42. Bauknecht, P.; Jékely, G. Ancient coexistence of norepinephrine, tyramine, and octopamine signaling in bilaterians. BMC Biol. 2017, 15, 6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Mustard, J.A.; Blenau, W.; Hamilton, I.S.; Ward, V.K.; Ebert, P.R.; Mercer, A.R. Analysis of two D1-like dopamine receptors from the honey bee Apis mellifera reveals agonist-independent activity. Brain Res. Mol. Brain Res. 2003, 113, 67–77. [Google Scholar] [CrossRef] [Green Version]
  44. Troppmann, B.; Balfanz, S.; Krach, C.; Baumann, A.; Blenau, W. Characterization of an invertebrate-type dopamine receptor of the American cockroach, Periplaneta americana. Int. J. Mol. Sci. 2014, 15, 629–653. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Feng, G.; Hannan, F.; Reale, V.; Hon, Y.Y.; Kousky, C.T.; Evans, P.D.; Hall, L.M. Cloning and functional characterization of a novel dopamine receptor from Drosophila melanogaster. J. Neurosci. 1996, 16, 3925–3933. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Thompson, J.D.; Higgins, D.G.; and Gibson, T.J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22, 4673–4680. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Rotte, C.; Krach, C.; Balfanz, S.; Baumann, A.; Walz, B.; Blenau, W. Molecular characterization and localization of the first tyramine receptor of the American cockroach (Periplaneta americana). Neuroscience 2009, 162, 1120–1133. [Google Scholar] [CrossRef] [PubMed]
  48. Wachten, S.; Schlenstedt, J.; Gauss, R.; Baumann, A. Molecular identification and functional characterization of an adenylyl cyclase from the honeybee. J. Neurochem. 2006, 96, 1580–1590. [Google Scholar] [CrossRef]
  49. Li, Y.; Hoffmann, J.; Li, Y.; Stephano, F.; Bruchhaus, I.; Fink, C.; Roeder, T. Octopamine controls starvation resistance, life span and metabolic traits in Drosophila. Sci. Rep. 2016, 6, 35359. [Google Scholar] [CrossRef] [Green Version]
  50. Sujkowski, A.; Ramesh, D.; Brockmann, A.; Wessells, R. Octopamine drives endurance exercise adaptations in Drosophila. Cell Rep. 2017, 21, 1809–1823. [Google Scholar] [CrossRef] [Green Version]
  51. Selcho, M.; Pauls, D. Linking physiological processes and feeding behaviors by octopamine. Curr. Opin. Insect Sci. 2019, 36, 125–130. [Google Scholar] [CrossRef]
  52. Ohta, H.; Utsumi, T.; Ozoe, Y. Amino acid residues involved in interaction with tyramine in the Bombyx mori tyramine receptor. Insect Mol. Biol. 2004, 13, 531–538. [Google Scholar] [CrossRef] [PubMed]
  53. Congreve, M.; Langmead, C.; Marshall, F.H. The use of GPCR structures in drug design. Adv. Pharmacol. 2011, 62, 1–36. [Google Scholar] [PubMed]
  54. Probst, W.C.; Snyder, L.A.; Schuster, D.I.; Brosius, J.; Sealfon, S.C. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol. 1992, 11, 1–20. [Google Scholar] [CrossRef] [PubMed]
  55. Kobilka, B.K. G protein coupled receptor structure and activation. Biochim. Biophys. Acta 2007, 1768, 794–807. [Google Scholar] [CrossRef] [Green Version]
  56. Karageorgos, V.; Venihaki, M.; Sakellaris, S.; Pardalos, M.; Kontakis, G.; Matsoukas, M.T.; Gravanis, A.; Margioris, A.; Liapakis, G. Current understanding of the structure and function of family B GPCRs to design novel drugs. Hormones 2018, 17, 45–59. [Google Scholar] [CrossRef] [Green Version]
  57. Bockaert, J.; Pin, J.P. Molecular tinkering of G protein-coupled receptors: An evolutionary success. EMBO J. 1999, 18, 1723–1729. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Jékely, G. Global view of the evolution and diversity of metazoan neuropeptide signaling. Proc. Natl. Acad. Sci. USA 2013, 110, 8702–8707. [Google Scholar] [CrossRef] [Green Version]
  59. Elphick, M.R.; Mirabeau, O.; Larhammar, D. Evolution of neuropeptide signalling systems. J. Exp. Biol. 2018, 221, jeb151092. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Balfanz, S.; Strünker, T.; Frings, S.; Baumann, A. A family of octopamine receptors that specifically induce cyclic AMP production or Ca2+ release in Drosophila melanogaster. J. Neurochem. 2005, 93, 440–451. [Google Scholar] [CrossRef] [PubMed]
  61. Han, K.A.; Millar, N.S.; Davis, R.L. A novel octopamine receptor with preferential expression in Drosophila mushroom bodies. J. Neurosci. 1998, 18, 3650–3658. [Google Scholar] [CrossRef] [Green Version]
  62. Hoff, M.; Balfanz, S.; Ehling, P.; Gensch, T.; Baumann, A. A single amino acid residue controls Ca2+ signaling by an octopamine receptor from Drosophila melanogaster. FASEB J. 2011, 25, 2484–2491. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. O’Dowd, B.F.; Hnatowich, M.; Caron, M.G.; Lefkowitz, R.J.; Bouvier, M. Palmitoylation of the human β2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J. Biol. Chem. 1989, 264, 7564–7569. [Google Scholar] [PubMed]
  64. Docherty, J.R. Subtypes of functional α1- and α2-adrenoceptors. Eur. J. Pharmacol. 1998, 361, 1–15. [Google Scholar] [CrossRef]
  65. Goldstein, I. Oral phentolamine: An alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction. Int. J. Impot. Res. 2000, 12, S75–S80. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Yamada, J.; Sugimoto, Y.; Noma, T.; Yoshikawa, T. Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats. Eur. J. Pharmacol. 1998, 359, 81–86. [Google Scholar] [CrossRef]
  67. Schlenstedt, J.; Balfanz, S.; Baumann, A.; Blenau, W. Am5-HT7: Molecular and pharmacological characterization of the first serotonin receptor of the honeybee (Apis mellifera). J. Neurochem. 2006, 98, 1985–1998. [Google Scholar] [CrossRef]
  68. Troppmann, B.; Balfanz, S.; Baumann, A.; Blenau, W. Inverse agonist and neutral antagonist actions of synthetic compounds at an insect 5-HT1 receptor. Br. J. Pharmacol. 2010, 159, 1450–1562. [Google Scholar] [CrossRef] [Green Version]
  69. Minhas, N.; Gole, J.W.D.; Orr, G.L.; Downer, R.G.H. Pharmacology of [3H]mianserin binding in the nerve cord of the American cockroach, Periplaneta americana. Arch. Insect Biochem. Physiol. 1987, 6, 191–201. [Google Scholar] [CrossRef]
  70. Roeder, T. High-affinity antagonists of the locust neuronal octopamine receptor. Eur. J. Pharmacol. 1990, 191, 221–224. [Google Scholar] [CrossRef]
  71. Blenau, W.; Balfanz, S.; Baumann, A. PeaTAR1B: Characterization of a second type 1 tyramine receptor of the American cockroach, Periplaneta americana. Int. J. Mol. Sci. 2017, 18, 2279. [Google Scholar] [CrossRef] [Green Version]
  72. Evans, P.D.; Maqueira, B. Insect octopamine receptors: A new classification scheme based on studies of cloned Drosophila G-protein coupled receptors. Invert. Neurosci. 2005, 5, 111–118. [Google Scholar] [CrossRef] [PubMed]
  73. Saudou, F.; Amlaiky, N.; Plassat, J.L.; Borrelli, E.; Hen, R. Cloning and characterization of a Drosophila tyramine receptor. EMBO J. 1990, 9, 3611–3617. [Google Scholar] [CrossRef] [PubMed]
  74. Vanden Broeck, J.; Vulsteke, V.; Huybrechts, R.; De Loof, A. Characterization of a cloned locust tyramine receptor cDNA by functional expression in permanently transformed Drosophila S2 cells. J. Neurochem. 1995, 64, 2387–2395. [Google Scholar] [CrossRef] [PubMed]
  75. Ohta, H.; Utsumi, T.; Ozoe, Y. B96Bom encodes a Bombyx mori tyramine receptor negatively coupled to adenylate cyclase. Insect Mol. Biol. 2003, 12, 217–223. [Google Scholar] [CrossRef]
  76. Hildebrandt, H.; Müller, U. Octopamine mediates rapid stimulation of protein kinase A in the antennal lobe of honeybees. J. Neurobiol. 1995, 27, 44–50. [Google Scholar] [CrossRef] [PubMed]
  77. Uzzan, A.; Dudai, Y. Aminergic receptors in Drosophila melanogaster: Responsiveness of adenylate cyclase to putative neurotransmitters. J. Neurochem. 1982, 38, 1542–1550. [Google Scholar] [CrossRef]
  78. Gole, J.W.; Orr, G.L.; Downer, R.G.H. Interaction of formamidines with octopamine-sensitive adenylate cyclase receptor in the nerve cord of Periplaneta americana L. Life Sci. 1983, 32, 2939–2947. [Google Scholar] [CrossRef]
  79. Orr, G.L.; Gole, J.W.D.; Downer, R.G.H. Characterisation of an octopamine-sensitive adenylate cyclase in haemocyte membrane fragments of the American cockroach, Periplaneta americana L. Insect Biochem. 1985, 15, 695–701. [Google Scholar] [CrossRef]
  80. Aoyama, M.; Nakane, T.; Ono, T.; Khan, M.A.; Ohta, H.; Ozoe, Y. Substituent-dependent, positive and negative modulation of Bombyx mori adenylate cyclase by synthetic octopamine/tyramine analogues. Arch. Insect Biochem. Physiol. 2001, 47, 1–7. [Google Scholar] [CrossRef]
  81. Orr, N.; Orr, G.L.; Hollingworth, R.M. The Sf9 cell line as a model for studying insect octopamine-receptors. Insect Biochem. Mol. Biol. 1992, 22, 591–597. [Google Scholar] [CrossRef]
  82. Van Poyer, W.; Torfs, H.; Poels, J.; Swinnen, E.; De Loof, A.; Akerman, K.; Vanden Broeck, J. Phenolamine-dependent adenylyl cyclase activation in Drosophila Schneider 2 cells. Insect Biochem. Mol. Biol. 2001, 31, 333–338. [Google Scholar] [CrossRef]
  83. Näsman, J.; Kukkonen, J.P.; Akerman, K.E. Dual signalling by different octopamine receptors converges on adenylate cyclase in Sf9 cells. Insect Biochem. Mol. Biol. 2002, 32, 285–293. [Google Scholar] [CrossRef]
  84. Röser, C.; Jordan, N.; Balfanz, S.; Baumann, A.; Walz, B.; Baumann, O.; Blenau, W. Molecular and pharmacological characterization of serotonin 5-HT2α and 5-HT7 receptors in the salivary glands of the blowfly Calliphora vicina. PLoS ONE 2012, 7, e49459. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Kozak, M. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 1984, 12, 857–872. [Google Scholar] [CrossRef]
  86. Kumar, S.; Stecher, G.; Tamura, K. MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets. Mol. Bio. Evol. 2016, 33, 1870–1874. [Google Scholar] [CrossRef] [Green Version]
  87. Saitou, N.; Nei, M. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 1987, 4, 406–425. [Google Scholar]
  88. Hall, T.A. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 1999, 41, 95–98. [Google Scholar]
  89. Ludwig, J.; Margalit, T.; Eismann, E.; Lancet, D.; Kaupp, U.B. Primary structure of cAMP-gated channel from bovine olfactory epithelium. FEBS Lett. 1990, 270, 24–29. [Google Scholar] [CrossRef] [Green Version]
  90. Chen, C.; Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 1987, 7, 2745–2752. [Google Scholar] [CrossRef]
Ijms 21 09334 g001 550
Figure 1. Structural characteristics of the amino acid sequence deduced for AmOctα2R. (a) Hydrophobicity profile of AmOctα2R. The profile was calculated according to the algorithm of Kyte and Doolittle [36] using a window size of 19 amino acids. Peaks with scores greater than 1.6 (dashed line) indicate possible transmembrane (TM) regions; (b) prediction of TM domains with TMHMM server v. 2.0 [37]. Putative TM domains are indicated in red. Extracellular regions are shown with a purple line, and intracellular regions are shown with a blue line; (c) color-coded (rainbow) three-dimensional (3D) model of the receptor as predicted by Phyre2 [38]. The extracellular N-terminus (N) and the intracellular C-terminus (C) are labeled. Note that the first 216 amino acid residues of AmOctα2R were omitted in this simulation.
Figure 1. Structural characteristics of the amino acid sequence deduced for AmOctα2R. (a) Hydrophobicity profile of AmOctα2R. The profile was calculated according to the algorithm of Kyte and Doolittle [36] using a window size of 19 amino acids. Peaks with scores greater than 1.6 (dashed line) indicate possible transmembrane (TM) regions; (b) prediction of TM domains with TMHMM server v. 2.0 [37]. Putative TM domains are indicated in red. Extracellular regions are shown with a purple line, and intracellular regions are shown with a blue line; (c) color-coded (rainbow) three-dimensional (3D) model of the receptor as predicted by Phyre2 [38]. The extracellular N-terminus (N) and the intracellular C-terminus (C) are labeled. Note that the first 216 amino acid residues of AmOctα2R were omitted in this simulation.
Ijms 21 09334 g001
Ijms 21 09334 g002 550
Figure 2. Phylogenetic relationships of monoaminergic receptors. Alignments were performed using Clustal W [46] by using the core amino-acid sequences of TM 1–4, TM 5, TM 6, and TM 7. The evolutionary history was inferred using the neighbor-joining method. The percentage of replicate trees, in which the associated taxa clustered together in the bootstrap test (10,000 replicates), are shown next to the branches. The tree was drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Poisson correction method and are in the units of the number of amino acid substitutions per site. The analysis involved 76 amino acid sequences. Human rhodopsin (HsRHOD) was used to root the tree. Receptor subclasses are given on the right. The abbreviations of species are shown in alphabetical order: Am, Apis mellifera; Dm, Drosophila melanogaster; Hs, Homo sapiens; Pa, Periplaneta americana; Pc, Priapulus caudatus; Pd, Platynereis dumerilii; Sk, Saccoglossus kowalevskii. Protostomian species names are highlighted in red, whereas deuterostomian species names are given in blue. The accession numbers and annotations of all sequences used in the phylogenetic analysis can be found in Supplementary Table S2.
Figure 2. Phylogenetic relationships of monoaminergic receptors. Alignments were performed using Clustal W [46] by using the core amino-acid sequences of TM 1–4, TM 5, TM 6, and TM 7. The evolutionary history was inferred using the neighbor-joining method. The percentage of replicate trees, in which the associated taxa clustered together in the bootstrap test (10,000 replicates), are shown next to the branches. The tree was drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the Poisson correction method and are in the units of the number of amino acid substitutions per site. The analysis involved 76 amino acid sequences. Human rhodopsin (HsRHOD) was used to root the tree. Receptor subclasses are given on the right. The abbreviations of species are shown in alphabetical order: Am, Apis mellifera; Dm, Drosophila melanogaster; Hs, Homo sapiens; Pa, Periplaneta americana; Pc, Priapulus caudatus; Pd, Platynereis dumerilii; Sk, Saccoglossus kowalevskii. Protostomian species names are highlighted in red, whereas deuterostomian species names are given in blue. The accession numbers and annotations of all sequences used in the phylogenetic analysis can be found in Supplementary Table S2.
Ijms 21 09334 g002
Ijms 21 09334 g003 550
Figure 3. Expression of AmOctα2R-hemagglutinin A (HA) in flpTM cells. (a) Western blot of membrane proteins (30 µg) from flpTM cells expressing AmOctα2R-HA receptors were not treated (lane 1) or treated with PNGaseF (lane 2). As a control, 30 µg of membrane proteins from nontransfected flpTM cells (lane 3) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted to a polyvinylidene difluoride (PVDF) membrane. The blot was probed with a rat anti-(hemagglutinin A) HA antibody. (b) The same blot as shown in (a) was subsequently probed with an antibody directed against the C-terminus of the cyclic nucleotide-gated (CNG) channel. The sizes of marker proteins in kDa are given on the left margin.
Figure 3. Expression of AmOctα2R-hemagglutinin A (HA) in flpTM cells. (a) Western blot of membrane proteins (30 µg) from flpTM cells expressing AmOctα2R-HA receptors were not treated (lane 1) or treated with PNGaseF (lane 2). As a control, 30 µg of membrane proteins from nontransfected flpTM cells (lane 3) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted to a polyvinylidene difluoride (PVDF) membrane. The blot was probed with a rat anti-(hemagglutinin A) HA antibody. (b) The same blot as shown in (a) was subsequently probed with an antibody directed against the C-terminus of the cyclic nucleotide-gated (CNG) channel. The sizes of marker proteins in kDa are given on the left margin.
Ijms 21 09334 g003
Ijms 21 09334 g004 550
Figure 4. Concentration-dependent effects of octopamine on intracellular cAMP in AmOctα2R-HA-expressing flpTM cells. Relative fluorescence (corresponding to the amount of cAMP) is given as the percentage of the value obtained with 10 µM NKH 477 (=100%), a water-soluble forskolin analog. All measurements were performed in the presence of 100 µM isobutylmethylxanthine (IBMX). In the range from 10−9 M to 10−6 M, the octopamine activation of AmOctα2R-HA led to a concentration-dependent decrease in the fluorescence signal. Conversely, an increase in the fluorescence signal was observed with octopamine concentrations of 3 × 10−6 M and higher. Data points represent the mean ± SD of four-fold determinations.
Figure 4. Concentration-dependent effects of octopamine on intracellular cAMP in AmOctα2R-HA-expressing flpTM cells. Relative fluorescence (corresponding to the amount of cAMP) is given as the percentage of the value obtained with 10 µM NKH 477 (=100%), a water-soluble forskolin analog. All measurements were performed in the presence of 100 µM isobutylmethylxanthine (IBMX). In the range from 10−9 M to 10−6 M, the octopamine activation of AmOctα2R-HA led to a concentration-dependent decrease in the fluorescence signal. Conversely, an increase in the fluorescence signal was observed with octopamine concentrations of 3 × 10−6 M and higher. Data points represent the mean ± SD of four-fold determinations.
Ijms 21 09334 g004
Ijms 21 09334 g005 550
Figure 5. Concentration-dependent effects of octopamine on relative fluorescence in nontransfected (control) flpTM cells. The concentration–response curves for octopamine were established in the absence (open circles) or presence (filled circles) of 10 µM NKH 477. Relative fluorescence is given as the percentage of the value obtained with 10 μM NKH 477 (=100%). All measurements were performed in the presence of 100 μM IBMX. In both conditions, higher octopamine concentrations led to an increase in fluorescence. Data points represent the mean ± SD of four values.
Figure 5. Concentration-dependent effects of octopamine on relative fluorescence in nontransfected (control) flpTM cells. The concentration–response curves for octopamine were established in the absence (open circles) or presence (filled circles) of 10 µM NKH 477. Relative fluorescence is given as the percentage of the value obtained with 10 μM NKH 477 (=100%). All measurements were performed in the presence of 100 μM IBMX. In both conditions, higher octopamine concentrations led to an increase in fluorescence. Data points represent the mean ± SD of four values.
Ijms 21 09334 g005
Ijms 21 09334 g006 550
Figure 6. Concentration-response curves for agonists on intracellular cAMP level in AmOctα2R-HA-expressing flpTM cells. Relative fluorescence (corresponding to the amount of cAMP) is given as the percentage of the value obtained with 10 µM NKH 477 (=100%). All measurements were performed in the presence of 100 µM IBMX. Data points represent the mean ± SD of four values from a typical experiment.
Figure 6. Concentration-response curves for agonists on intracellular cAMP level in AmOctα2R-HA-expressing flpTM cells. Relative fluorescence (corresponding to the amount of cAMP) is given as the percentage of the value obtained with 10 µM NKH 477 (=100%). All measurements were performed in the presence of 100 µM IBMX. Data points represent the mean ± SD of four values from a typical experiment.
Ijms 21 09334 g006
Ijms 21 09334 g007 550
Figure 7. Effects of putative antagonists on tyramine-activated AmOctα2R-HA. The concentration series of the substances were applied in the presence of 10 µM NKH 477, 10 µM tyramine, and 100 µM IBMX. Ligands used were (a) phnetolamine, (b) epinastine, (c) mainserin, and (d) yohimbine. Data represent the mean ± SD of four values from a typical experiment. All determinations were independently repeated at least three times.
Figure 7. Effects of putative antagonists on tyramine-activated AmOctα2R-HA. The concentration series of the substances were applied in the presence of 10 µM NKH 477, 10 µM tyramine, and 100 µM IBMX. Ligands used were (a) phnetolamine, (b) epinastine, (c) mainserin, and (d) yohimbine. Data represent the mean ± SD of four values from a typical experiment. All determinations were independently repeated at least three times.
Ijms 21 09334 g007
Table
Table 1. Mean values for the half-maximal stimulation (EC50 [M] and logEC50 ± SD) for octopamine and tyramine on AmOctα2R-HA. Values were obtained from the nonlinear fitting of the data (n = the number of experiments) from concentration–response curves (GraphPad Prism 5.04).
Table 1. Mean values for the half-maximal stimulation (EC50 [M] and logEC50 ± SD) for octopamine and tyramine on AmOctα2R-HA. Values were obtained from the nonlinear fitting of the data (n = the number of experiments) from concentration–response curves (GraphPad Prism 5.04).
Octopamine (n = 7)Tyramine (n = 11)
EC50 [M]5.87 × 10−81.85 × 10−6
logEC50−7.43 ± 0.24−5.78 ± 0.17
Table
Table 2. Mean values for the half-maximal inhibition (IC50 [M] and logIC50 ± SD) for substances with antagonistic activity on tyramine-activated AmOctα2R. Values were obtained from the nonlinear fitting of the data (n = number of experiments) from concentration–response curves (GraphPad Prism 5.04).
Table 2. Mean values for the half-maximal inhibition (IC50 [M] and logIC50 ± SD) for substances with antagonistic activity on tyramine-activated AmOctα2R. Values were obtained from the nonlinear fitting of the data (n = number of experiments) from concentration–response curves (GraphPad Prism 5.04).
SubstanceSpecificity in Humans 1IC50 [M]logIC50Maximal Inhibition [%]n
5-CTagonist at 5-HT1A, 5-HT1B, 5-HT1D, 5-HT5, and 5-HT7 receptors4.16 × 10−9−8.48 ± 0.2010.83
phentolaminenonselective α-adrenergic antagonist5.63 × 10−9−8.30 ± 0.2016.13
epinastinenonsedating histamine H1 receptor antagonist1.98 × 10−8−7.75 ± 0.2917.316
5-MTagonist at 5-HT1, 5-HT2, 5-HT4, 5-HT6, and 5-HT7 receptors2.06 × 10−8−7.72 ± 0.2020.34
mianserinantagonist at the histamine H1, 5-HT1D, 5-HT2A, 5-HT2C, 5-HT3, 5-HT6, 5-HT7, α1-adrenergic and α2-adrenergic receptors2.95 × 10−8−7.71 ± 0.3121.55
yohimbinehigh affinity for the α2-adrenergic receptor, moderate affinity for the α1-adrenergic, 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1F, 5-HT2B, and D2 receptors, and weak affinity for the 5-HT1E, 5-HT2A, 5-HT5A, 5-HT7, and D3 receptors; behaves as an antagonist at α1-adrenergic, α2-adrenergic, 5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B and D2, and as a partial agonist at 5-HT1A8.14 × 10−8−7.12 ± 0.3214.34
ketanserinaffinity for multiple GPCR; antagonist at 5-HT2A and 5-HT2C receptors; high affinity for α1-adrenergic receptors and very high affinity for histamine H1 receptors; moderate affinity for α2-adrenergic and 5-HT6 receptors as well as weak affinity for dopamine D1 and D2 receptors5.14 × 10−7−6.29 ± 0.2917.113
8-OH-DPATstandard selective 5-HT1A agonist; also has moderate affinity for 5-HT7 receptors1.09 × 10−6−6.15 ± 0.367.213
AS-19agonist at the 5-HT7 receptorno effect 6
1 These data have been obtained from the websites of Tocris (https://www.tocris.com/) and/or Sigma-Aldrich (https://www.sigmaaldrich.com).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Blenau, W.; Wilms, J.A.; Balfanz, S.; Baumann, A. AmOctα2R: Functional Characterization of a Honeybee Octopamine Receptor Inhibiting Adenylyl Cyclase Activity. Int. J. Mol. Sci. 2020, 21, 9334. https://doi.org/10.3390/ijms21249334

AMA Style

Blenau W, Wilms JA, Balfanz S, Baumann A. AmOctα2R: Functional Characterization of a Honeybee Octopamine Receptor Inhibiting Adenylyl Cyclase Activity. International Journal of Molecular Sciences. 2020; 21(24):9334. https://doi.org/10.3390/ijms21249334

Chicago/Turabian Style

Blenau, Wolfgang, Joana Alessandra Wilms, Sabine Balfanz, and Arnd Baumann. 2020. "AmOctα2R: Functional Characterization of a Honeybee Octopamine Receptor Inhibiting Adenylyl Cyclase Activity" International Journal of Molecular Sciences 21, no. 24: 9334. https://doi.org/10.3390/ijms21249334

APA Style

Blenau, W., Wilms, J. A., Balfanz, S., & Baumann, A. (2020). AmOctα2R: Functional Characterization of a Honeybee Octopamine Receptor Inhibiting Adenylyl Cyclase Activity. International Journal of Molecular Sciences, 21(24), 9334. https://doi.org/10.3390/ijms21249334

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop